How COX-2 Inhibition Affects Colorectal Cancer Growth
Author Information
Author(s): Yao M, Song D H, Rana B, Wolfe M M
Primary Institution: Boston University School of Medicine and Boston Medical Center
Hypothesis
Can COX-2 selective inhibition reverse the trophic properties of gastrin in colorectal cancer?
Conclusion
Selective COX-2 inhibition can reverse the growth-promoting effects of gastrin in colorectal cancer.
Supporting Evidence
- Gastrin increases colon cancer cell proliferation and tumor growth.
- COX-2 selective inhibition with NS-398 reverses the effects of gastrin.
- Increased COX-2 expression and activity were observed with gastrin treatment.
- Tumor growth was significantly reduced in mice treated with NS-398.
Takeaway
Gastrin helps cancer cells grow, but a specific medicine can stop this growth.
Methodology
The study involved in vitro and in vivo experiments using mouse colon cancer cells and a mouse model to assess the effects of gastrin and COX-2 inhibition.
Limitations
Further studies are needed to clarify the cellular and molecular mechanisms involved.
Participant Demographics
Male BALB/C mice aged 6-10 weeks were used in the animal studies.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website